跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
醫學系內科學科
醫學院
醫學系
概覽
指紋
網路
人員
(18)
研究成果
(2762)
獎項
(27)
活動
(85)
指紋
查看啟用 醫學系內科學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Taiwan
100%
Atrial Fibrillation
91%
Catheter Ablation
55%
Confidence Interval
37%
Clinical Outcomes
33%
Hypertension
32%
Hazard Ratio
30%
Risk Factors
26%
Atrial Fibrillation Ablation
26%
Heart Failure
25%
Paroxysmal Atrial Fibrillation
24%
Ablation
24%
Ventricular Arrhythmia
22%
Blood Pressure
22%
National Cohort Study
21%
Asia
18%
Hemodialysis Patients
18%
Taiwanese
18%
All-cause Mortality
16%
Hypertension Management
16%
Cardiovascular Mortality
16%
Pulmonary Vein Isolation
16%
Odds Ratio
15%
Pulmonary Vein
15%
Atrial Substrate
15%
Ca2+
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Cirrhosis
14%
Systolic Blood Pressure
14%
Type 2 Diabetic Patients
14%
Left Atrium
14%
High Risk
14%
Southern Taiwan
14%
Portal Hypertension
13%
Multivariate Analysis
13%
Atrial Fibrillation Recurrence
12%
Hepatocellular Carcinoma
12%
Heart Failure with Preserved Ejection Fraction (HFpEF)
12%
Persistent Atrial Fibrillation
12%
Rheumatoid Arthritis
12%
Meta-analysis
12%
Cardiovascular Risk
11%
Systemic Lupus Erythematosus
11%
Electrophysiological Characteristics
11%
Hemodialysis
11%
Taiwan Society of Cardiology
11%
Prognostic Factors
11%
Clinical Characteristics
11%
Liver Cirrhosis
11%
Central Blood Pressure
11%
Left Ventricular Ejection Fraction
10%
CHA2DS2-VASc Score
10%
Chronic Kidney Disease
10%
Left Atrial
10%
Randomized Controlled Trial
10%
SHP-1
9%
Chemotherapy
9%
Overall Survival
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Diabetes
9%
Percutaneous Coronary Intervention
9%
Coronary Artery Disease
9%
Clinical Significance
9%
Ventricular Tachycardia
9%
End-stage Renal Disease
9%
Induced Apoptosis
9%
Metabolic Syndrome
9%
Systematic Meta-analysis
9%
General Hospital
9%
High Incidence
9%
Cardiovascular Disease
8%
Des-acyl Ghrelin
8%
Patients with Heart Failure
8%
Acute Heart Failure
8%
Cirrhotic Patients
8%
Medical Center
8%
Sacubitril-valsartan
8%
Body Mass Index
8%
Apoptosis
8%
Sinus Rhythm
8%
Intensive Care Unit
8%
COVID-19
8%
Electrogram
8%
Tumor Necrosis Factor-α
8%
Arrhythmogenic Right Ventricular Cardiomyopathy
8%
Portal Hypertensive
8%
Myocardial Infarction
8%
Portal Pressure
8%
Asian Patients
8%
Cardiovascular Events
8%
Medical Students
8%
Dominant Frequency
8%
Tuberculosis
7%
Ischemic Stroke
7%
Comorbidity
7%
Non-paroxysmal Atrial Fibrillation
7%
High Prevalence
7%
Cardiovascular Outcomes
7%
Right Atrial
7%
CIP2A
7%
Medicine and Dentistry
Atrial Fibrillation
86%
Ablation
60%
Blood Pressure
39%
Cardiovascular System
33%
Congestive Heart Failure
30%
Disease
28%
Recurrent Disease
27%
Cohort Analysis
24%
Apoplexy
24%
Prevalence
23%
Liver Cirrhosis
22%
Hazard Ratio
22%
Paroxysmal Atrial Fibrillation
21%
Hemodialysis
18%
Ventricular Tachycardia
17%
Hemodynamic
16%
Pulmonary Vein
16%
Cardiovascular Disease
16%
Pulmonary Vein Isolation
15%
Systolic Blood Pressure
15%
Infection
14%
Heart Ventricle Arrhythmia
14%
Cardiology
14%
Pulse Wave Velocity
13%
Electrography
13%
Coronary Artery Disease
13%
Left Atrium
12%
Neoplasm
12%
Diabetes Mellitus
12%
Chronic Kidney Disease
12%
End Stage Renal Disease
11%
Maturity Onset Diabetes of the Young
11%
Breast Cancer
11%
Arrhythmogenic Right Ventricular Dysplasia
11%
Odds Ratio
11%
Diabetes
11%
Drug Therapy
10%
Portal Hypertension
10%
Prognostic Factor
10%
Cardiovascular Risk
10%
Antithrombotic
10%
Systemic Lupus Erythematosus
10%
Supraventricular Tachycardia
9%
Multivariate Analysis
9%
All Cause Mortality
9%
Persistent Atrial Fibrillation
9%
Malignant Neoplasm
9%
Hepatocellular Carcinoma
9%
Intensive Care Unit
9%
Randomized Controlled Trial
8%
Meta-Analysis
8%
Atrial Fibrillation Ablation
8%
Blood Pressure Monitoring
8%
COVID-19
8%
Adverse Event
8%
Overall Survival
8%
Chemotherapy
8%
Atrial Flutter
8%
CHA2DS2-VASc Score
8%
Sinus Rhythm
8%
Electrocardiogram
8%
Percutaneous Coronary Intervention
8%
Proportional Hazards Model
7%
Angiogenesis
7%
Myocardial Disease
7%
Body Mass Index
7%
Rheumatoid Arthritis
7%
Inflammatory Arthritis
7%
Brain Ischemia
7%
Heart Left Ventricle Ejection Fraction
7%
Patient with Type 2 Diabetes
7%
Diagnosis
7%
Mortality Rate
7%
Kidney Function
7%
Acute Decompensated Heart Failure
7%
Myocardial Infarction
7%
Peritoneal Dialysis
7%
Observational Study
7%
Cardiovascular Mortality
7%
Heart Failure with Reduced Ejection Fraction
7%
Risk Stratification
7%
C Reactive Protein
7%
Systematic Review
6%
Human Immunodeficiency Virus
6%
Tumor Necrosis Factor
6%
Ejection Fraction
6%
Ghrelin
6%
Ablation Therapy
6%
Portal Venous Pressure
6%
Pulse Rate
6%
Sudden Cardiac Death
6%
Arterial Stiffness
6%
Comorbidity
6%
Superior Vena Cava
6%
Tachyarrhythmia
6%
Programmed Cell Death
6%
Bleeding
6%
Cardiac Dysrhythmia
6%
Clinical Significance
6%
In Vitro
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
61%
Congestive Heart Failure
35%
Disease
30%
Cohort Study
30%
Prevalence
24%
Hemodialysis
22%
Cerebrovascular Accident
21%
Liver Cell Carcinoma
21%
Recurrent Disease
20%
Cardiovascular Disease
19%
Liver Cirrhosis
17%
Infection
17%
Diabetes Mellitus
13%
Non Insulin Dependent Diabetes Mellitus
13%
Calcium Ion
13%
Adverse Event
13%
Heart Ventricle Arrhythmia
12%
Rheumatoid Arthritis
12%
Inflammatory Arthritis
12%
Chemotherapy
12%
Paroxysmal Atrial Fibrillation
12%
All Cause Mortality
12%
Coronary Artery Disease
12%
Breast Cancer
11%
Chronic Kidney Failure
11%
Inflammation
11%
Anticoagulant Agent
10%
Colorectal Carcinoma
10%
End Stage Renal Disease
10%
Portal Hypertension
10%
Neoplasm
10%
Randomized Controlled Trial
10%
Malignant Neoplasm
10%
Heart Right Ventricle Dysplasia
9%
Tumor Necrosis Factor
9%
Heart Ventricle Tachycardia
9%
Overall Survival
9%
Valsartan/Sacubitril
8%
Creatinine
8%
C Reactive Protein
8%
Observational Study
8%
Myocardial Disease
8%
Cardiovascular Risk
8%
Brain Ischemia
7%
Sorafenib
7%
Hepatitis B Virus
7%
Heart Failure with Reduced Ejection Fraction
7%
Nonalcoholic Fatty Liver
7%
Combination Therapy
7%
Metabolic Syndrome X
7%
Systemic Lupus Erythematosus
7%
Remission
7%
Mortality Rate
7%
Syndrome
6%
HIV
6%
Heart Infarction
6%
Comorbidity
6%
Adult Respiratory Distress Syndrome
6%
Carbapenem
6%
Cytokine
6%
Cardiovascular Mortality
6%
Antihypertensive Agent
6%
Heart Arrhythmia
6%
Arteriovenous Fistula
5%
Ghrelin
5%
Kidney Disease
5%
Warfarin
5%
Chronic Hepatitis B
5%
Retrospective Study
5%
Receptor
5%
Bloodstream Infection
5%
Chronic Obstructive Lung Disease
5%
Rituximab
5%
Angiotensin Receptor
5%
Placebo
5%
Hepatic Encephalopathy
5%
Nonhodgkin Lymphoma
5%